Terms: = Head and neck cancer AND Cytokeratin fragment 21-1
4 results:
1. Non-invasive bioassay of Cytokeratin Fragment 21.1 (Cyfra 21.1) protein in human saliva samples using immunoreaction method: An efficient platform for early-stage diagnosis of oral cancer based on biomedicine.
Jafari M; Hasanzadeh M
Biomed Pharmacother; 2020 Nov; 131():110671. PubMed ID: 32853907
[TBL] [Abstract] [Full Text] [Related]
2. Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders.
Rathore AS; Katyal S; Jain A; Shetty DC
J Cancer Res Ther; 2020; 16(3):452-457. PubMed ID: 32719250
[TBL] [Abstract] [Full Text] [Related]
3. [The clinical signifinace of CEA, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
[No Abstract] [Full Text] [Related]
4. L-cysteine capped lanthanum hydroxide nanostructures for non-invasive detection of oral cancer biomarker.
Tiwari S; Gupta PK; Bagbi Y; Sarkar T; Solanki PR
Biosens Bioelectron; 2017 Mar; 89(Pt 2):1042-1052. PubMed ID: 27825517
[TBL] [Abstract] [Full Text] [Related]
